Alterations in lipids and adipocyte hormones in female-to-male transsexuals

International Journal of Endocrinology

Volumn 2010, Issue , 2010, Pages

  Tangpricha, Vin ^a   Chandra, Prakash ^a   Basra, Sukhdeep S ^b   Chen, Tai C ^c  

^a Division of Endocrinology   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN; RESISTIN; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANDROGEN THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FEMALE TO MALE TRANSSEXUAL; HEMATOCRIT; HORMONE BLOOD LEVEL; HUMAN; LEPTIN BLOOD LEVEL; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; THROMBOCYTE COUNT;

EID: 79952234991     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2010/945053     Document Type: Article

References (25)

1. Hembree W. C., Cohen-Kettenis P., Delemarre-Van De Waal H. A., Gooren L. J., Meyer W. J. III, Spack N. P., Tangpricha V., Montori V. M., Endocrine treatment of transsexual persons: an endocrine society clinical practice guideline Journal of Clinical Endocrinology and Metabolism 2009 94 9 3132 3154
2. Tangpricha V., Ducharme S. H., Barber T. W., Chipkin S. R., Endocrinologic treatment (Pubitemid 36790106)
3. Elamin M. B., Garcia M. Z., Murad M. H., Erwin P. J., Montori V. M., Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses Clinical Endocrinology 2010 72 1 1 10
4. Goh H. H., Loke D. F. M., Ratnam S. S., The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women Maturitas 1995 21 1 65 70
5. Giltay E. J., Toorians A. W. F. T., Sarabjitsingh A. R., de Vries N. A., Gooren L. J. G., Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals Journal of Endocrinology 2004 180 1 107 112 (Pubitemid 38180762)
6. Jacobeit J. W., Gooren L. J., Schulte H. M., Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals European Journal of Endocrinology 2009 161 5 795 798
7. Gooren L. J., Giltay E. J., Bunck M. C., Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience Journal of Clinical Endocrinology and Metabolism 2008 93 1 19 25
8. Elbers J. M. H., Giltay E. J., Teerlink T., Scheffer P. G., Asscheman H., Seidell J. C., Gooren L. J. G., Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects Clinical Endocrinology 2003 58 5 562 571 (Pubitemid 36566798)
9. Elbers J. M. H., De Jong S., Teerlink T., Asscheman H., Seidell J. C., Gooren L. J. G., Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals Metabolism 1999 48 11 1371 1377 (Pubitemid 29536435)
10. Page S. T., Herbst K. L., Amory J. K., Coviello A. D., Anawalt B. D., Matsumoto A. M., Bremner W. J., Testosterone administration suppresses adiponectin levels in men Journal of Andrology 2005 26 1 85 92 (Pubitemid 39665280)
11. Elbers J. M. H., Asscheman H., Seidell J. C., Frlich M., Meinders A. E., Gooren L. J. G., Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals Journal of Clinical Endocrinology and Metabolism 1997 82 10 3267 3270 (Pubitemid 27419069)
12. Resmini E., Andraghetti G., Rebora A., Cordera R., Vera L., Giusti M., Minuto F., Ferone D., Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments Journal of Andrology 2008 29 5 580 585
13. Carmina E., Orio F., Palomba S., Cascella T., Longo R. A., Colao A. M., Lombardi G., Lobo R. A., Evidence for altered adipocyte function in polycystic ovary syndrome European Journal of Endocrinology 2005 152 3 389 394 (Pubitemid 40439491)
14. Turner A., Chen T. C., Barber T. W., Malabanan A. O., Holick M. F., Tangpricha V., Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects Clinical Endocrinology 2004 61 5 560 566 (Pubitemid 39545171)
15. Mueller A., Kiesewetter F., Binder H., Beckmann M. W., Dittrich R., Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals Journal of Clinical Endocrinology and Metabolism 2007 92 9 3470 3475 (Pubitemid 47435322)
16. Jacobeit J. W., Gooren L. J., Schulte H. M., Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals Journal of Sexual Medicine 2007 4 5 1479 1484 (Pubitemid 47337697)
17. Mantzoros C. S., The role of leptin in human obesity and disease: a review of current evidence Annals of Internal Medicine 1999 130 8 671 680 (Pubitemid 29196202)
18. Sierra-Johnson J., Romero-Corral A., Lopez-Jimenez F., Gami A. S., Sert Kuniyoshi F. H., Wolk R., Somers V. K., Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population American Journal of Cardiology 2007 100 2 234 239
19. Romero-Corral A., Sierra-Johnson J., Lopez-Jimenez F., Thomas R. J., Singh P., Hoffmann M., Okcay A., Korinek J., Wolk R., Somers V. K., Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population Nature Clinical Practice Cardiovascular Medicine 2008 5 7 418 425 (Pubitemid 351935576)
20. Javor E. D., Ghany M. G., Cochran E. K., Oral E. A., DePaoli A. M., Premkumar A., Kleiner D. E., Gorden P., Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy Hepatology 2005 41 4 753 760 (Pubitemid 40462937)
21. Berra M., Armillotta F., D'emidio L., Costantino A., Martorana G., Pelusi G., Meriggiola M. C., Testosterone decreases adiponectin levels in female to male transsexuals Asian Journal of Andrology 2006 8 6 725 729 (Pubitemid 44869622)
22. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes Nature 2001 409 6818 307 312 (Pubitemid 32151228)
23. Norata G. D., Ongari M., Garlaschelli K., Raselli S., Grigore L., Catapano A. L., Plasma resistin levels correlate with determinants of the metabolic syndrome European Journal of Endocrinology 2007 156 2 279 284 (Pubitemid 46554524)
24. Seow K.-M., Juan C.-C., Wu L.-Y., Hsu Y.-P., Yang W.-M., Tsai Y.-L., Hwang J.-L., Ho L.-T., Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance Human Reproduction 2004 19 1 48 53 (Pubitemid 38072005)
25. Yilmaz M., Bukan N., Demirc H., ztrk., Kan E., Ayvaz G., Arslan M., Serum resistin and adiponectin levels in women with polycystic ovary syndrome Gynecological Endocrinology 2009 25 4 246 252